Epsilon M&A Deal Report - NewCo Pharma Group
Transaction Multiples for the Valuation of Private Companies
Medios / NewCo Pharma Group
No EMAT :
109809
Announced Date :
25/11/2021
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Medios
Target :
NewCo Pharma Group
Country :
Germany
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Founded in 2014, NewCo Pharma Group is a national network with 5 compounding facilities with >200,000 preparations and wholesale with focus on northern, western and southern Germany. > The NewCo...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 128
| Date | Acquirer | Target | Country | Multiples | See details |
| 30/09/2020 | DomusVi | La Barillière | Calvados | *** | 109797 |
| 30/11/2021 | Emera Exploitations | Mediaustral Reunion | France | * | 109764 |
Source: Epsilon Research / EMAT
